MorphoSys

MorphoSys EBIT per Share

Delisted

The EBIT per Share of MorphoSys (MOR.DE) as of Oct 9, 2026 is -6.34 EUR. In the previous year, EBIT per Share was -6.46 EUR — a change of -1.84% (higher).

EBIT per Share

-6.34EUR

YoY

-1.84%

Last updated:

EBIT per Share of MorphoSys is 2023 -6.34 EUR. EBIT per Share of MorphoSys was 2022 -6.46 EUR. It decreases by -1.84% higher compared to the previous year.

The MorphoSys EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
-6.34 EUR
Jan 1, 2024 (e)
-4.81 EUR
Jan 1, 2025 (e)
-2.83 EUR
Jan 1, 2026 (e)
-0.41 EUR
Jan 1, 2027 (e)
7.33 EUR
Jan 1, 2028 (e)
10.41 EUR
Jan 1, 2029 (e)
0.76 EUR
Jan 1, 2030 (e)
1.34 EUR
The MorphoSys EBIT per Share history
YEAREBIT per ShareYoY
est1.34EUR+77.42%
est0.76EUR-92.72%
est10.41EUR+42.05%
est7.33EUR-1,891.40%
est-0.41EUR-85.56%
est-2.83EUR-41.11%
est-4.81EUR-24.12%
-6.34EUR-1.84%
-6.46EUR-13.98%
-7.51EUR-1,468.90%
0.55EUR-116.04%
-3.42EUR+78.71%
-1.91EUR-19.08%
-2.37EUR+3.19%
-2.29EUR-384.96%
0.80EUR-1,288.33%
-0.07EUR-116.30%
0.42EUR+287.08%
0.11EUR-79.86%
0.53EUR+23.95%
0.43EUR-14.79%
0.50EUR-31.41%
0.74EUR+126.93%
0.32EUR+1.40%
0.32EUR-12.37%
0.36EUR+842.16%
0.04EUR—
Access this data via the Eulerpool API
Get Free API Key

MorphoSys Stock analysis

What does MorphoSys do? MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MorphoSys stock

EBIT per Share of MorphoSys is -6.34 EUR in 2023.

EBIT per Share of MorphoSys changed from -6.46 EUR to -6.34 EUR, representing a -1.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share MorphoSys since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — MorphoSys

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — MorphoSys